Neutrophils protect lymphoma cells against cytotoxic and targeted therapies through CD11b/ICAM-1 binding.

Hirz, Taghreed; Matera, Eva-Laure; Chettab, Kamel; Jordheim, Lars Petter; Mathé, Doriane; Evesque, Anne; Esmenjaud, Justine; Salles, Gilles; Dumontet, Charles

Hirz, Taghreed; Matera, Eva-Laure; Chettab, Kamel; Jordheim, Lars Petter; Mathé, Doriane; Evesque, Anne; Esmenjaud, Justine; Salles, Gilles; Dumontet, Charles.

Afiliação

Hirz T; Anticancer Antibody Team, INSERM U1052, CNRS UMR 5286, Cancer Research Center of Lyon, University of Lyon, Lyon, France.
Matera EL; Anticancer Antibody Team, INSERM U1052, CNRS UMR 5286, Cancer Research Center of Lyon, University of Lyon, Lyon, France.
Chettab K; Anticancer Antibody Team, INSERM U1052, CNRS UMR 5286, Cancer Research Center of Lyon, University of Lyon, Lyon, France.
Jordheim LP; Anticancer Antibody Team, INSERM U1052, CNRS UMR 5286, Cancer Research Center of Lyon, University of Lyon, Lyon, France.
Mathé D; Anticancer Antibody Team, INSERM U1052, CNRS UMR 5286, Cancer Research Center of Lyon, University of Lyon, Lyon, France.
Evesque A; Anticancer Antibody Team, INSERM U1052, CNRS UMR 5286, Cancer Research Center of Lyon, University of Lyon, Lyon, France.
Esmenjaud J; Anticancer Antibody Team, INSERM U1052, CNRS UMR 5286, Cancer Research Center of Lyon, University of Lyon, Lyon, France.
Salles G; Hospices Civils de Lyon, Department of Hematology, Pierre-Benite, France.
Dumontet C; Université Claude Bernard Lyon-1, Lyon, France.

Oncotarget ; 8(42): 72818-72834, 2017 Sep 22.

Article em En | MEDLINE | ID: mdl-29069828

Palavras-chave

cell-cell interactions; chemotherapy; lymphoma; neutrophils; targeted therapy

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Oncotarget Ano de publicação: 2017 Tipo de documento: Article País de afiliação: França

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google